---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-23-000002"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:33:59.414226+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Exagen provides preliminary Q4 and FY 2022 AVISE CTD unit volumes, Q1 2023 revenue guidance

## Summary
- Delivered ~33,800 AVISE CTD units in Q4 2022; ~135,000 units for full year 2022.
- Expects Q1 2023 revenue between $8.2M and $9.2M.
- Estimates profitability achievable at $75M annual revenue assuming 60% gross margin.

## SEC filing metadata
- accession: 0001274737-23-000002
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/0001274737-23-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/exdx-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-23-000002
- JSON: https://secwatch.observer/filing/0001274737-23-000002.json
- Plain text: https://secwatch.observer/filing/0001274737-23-000002.txt

## Key facts
- Earnings Releases
  EXAGEN INC. reported preliminary financial results for the three months ended December 31, 2022.
  - Period: the three months ended December 31, 2022
  - Result: preliminary results
  source text: The Company is providing certain preliminary financial information and results of operations for the three months and year ended December 31, 2022, based on currently available information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/0001274737-23-000002-index.htm
- Earnings Releases
  EXAGEN INC. reported preliminary financial results for the year ended December 31, 2022.
  - Period: the year ended December 31, 2022
  - Result: preliminary results
  source text: The Company is providing certain preliminary financial information and results of operations for the three months and year ended December 31, 2022, based on currently available information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000002/0001274737-23-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.